Financials MEDICLIN AG

Stocks

Real-time Estimate Tradegate 10:31:42 2026-10-29 EDT			5-day change	1st Jan Change
5.275 ^EUR	+0.48%		0.00%	+44.59%

07-31	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-04	MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	673.1	704.7	730.1	748.8	784.5	787.5	803.2	819.3
Change	-	4.69%	3.6%	2.56%	4.77%	0.38%	2%	2%
EBITDA ¹	85.22	90.92	98.73	103.8	115.6	114.3	115.3	115.6
Change	-	6.69%	8.58%	5.11%	11.39%	-1.14%	0.87%	0.32%
EBIT ¹	11.56	19.52	12.72	53.49	55.36	62.11	62.47	62.72
Change	-	68.81%	-34.83%	320.43%	3.51%	12.19%	0.57%	0.41%
Interest Paid	-	-	-	-	-	-	-	-
Earnings before Tax (EBT)	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Net income ¹	1.461	9.441	-10.78	24.84	25.49	36.66	38.2	40.12
Change	-	545.98%	-214.15%	330.5%	2.6%	43.85%	4.18%	5.03%
Announcement Date	3/30/22	3/31/23	3/27/24	3/28/25	3/27/26	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	3/30/22	3/31/23	3/27/24	3/28/25	3/27/26	-	-	-

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025
CAPEX ¹	22.25	15.23	24.37	34.42	38.04	48.43
Change	-	-31.56%	60.01%	41.23%	10.53%	27.3%
Free Cash Flow (FCF) ¹	80.55	50.92	7.023	12.09	34.75	9.144
Change	-	-36.79%	-86.21%	72.12%	187.49%	-73.69%
Announcement Date	3/8/21	3/30/22	3/31/23	3/27/24	3/28/25	3/27/26

¹EUR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	12.66%	12.9%	13.52%	13.86%	14.73%	14.51%	14.35%	14.11%
EBIT Margin (%)	-	1.72%	2.77%	1.74%	7.14%	7.06%	7.89%	7.78%	7.66%
EBT Margin (%)	-	-	-	-	-	-	-	-	-
Net margin (%)	-	0.22%	1.34%	-1.48%	3.32%	3.25%	4.66%	4.76%	4.9%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-	-
Profitability
ROA	-0.65%	0.2%	0.72%	2.5%	3.53%	4.31%	-	-	-
ROE	-4.92%	0.83%	4.95%	-5.29%	11.9%	10.97%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	0.04	0.04	0.04	0.04
Change	-	-	-	-	-	-	0%	0%	0%
Book Value Per Share ¹	-	3.86	4.4	4.125	4.684	5.241	5.99	6.75	7.56
Change	-	-	13.99%	-6.25%	13.56%	11.88%	14.29%	12.69%	12%
EPS ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Nbr of stocks (in thousands)	-	47,500	47,500	47,500	47,500	47,500	47,500	47,500	47,500
Announcement Date	-	3/30/22	3/31/23	3/27/24	3/28/25	3/27/26	-	-	-